Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Efficacy analysis of individualized surgical strategies for extracranial carotid artery aneurysms based on aneurysm location and parent-artery lesion characteristics].

Zhonghua yi xue za zhi·2026

Same author

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

ESMO open·2025

Same author

[Study on the association between systemic immune-inflammation index and metabolic types and characteristics of obesity in children and adolescents].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Same author

Monatomic glass formation through competing order balance.

Nature communications·2025

Same author

[Clinicopathological features of lymphoepithelioma-like carcinoma with abnormal expression of follicular dendritic cell markers: report of four cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2025

Same author

[The mediating effect of electrocardiographic indicators in the association between exposure to fine particulate matter and its element constituents and blood pressure].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015

Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014

Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014

Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014

Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014

Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic adenoviral vectors.

R Alemany¹, W W Zhang

¹Wallace Tumor Institute, Department of Medicine-Pulmonary and Critical Care, University of Alabama, Birmingham, AL.

Methods in Molecular Medicine

|March 11, 2011

Summary

This summary is machine-generated.

Analyzing mutations in viral vectors is crucial for safe and effective gene therapy. Understanding how these mutations impact viral replication and production in normal cells informs potential therapeutic applications and dosage strategies.

More Related Videos

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Area of Science:

Virology
Gene Therapy
Oncology

Background:

Viral vectors are utilized in gene therapy and cancer treatment.
Mutations in viral vectors can alter their behavior and efficacy.
Understanding these alterations is key to optimizing therapeutic strategies.

Purpose of the Study:

To evaluate the impact of specific mutations on viral replication in normal cells.
To assess how these mutations affect viral burst size (virus production per cell).
To inform the safe and effective application of engineered viral vectors.

Main Methods:

Analysis of viral replication kinetics in normal cell lines.
Quantification of viral particle production (burst size) post-infection.
Comparison of mutant viral strains with wild-type counterparts.

Main Results:

Mutations were found to modulate viral replication efficiency in normal cells.
Viral burst size was significantly affected by the introduced mutations.
The degree of abrogation varied depending on the specific mutation analyzed.

Conclusions:

Engineered viral vectors with controlled replication offer potential for higher therapeutic doses.
Mutations impacting burst size necessitate careful consideration for viral propagation dynamics.
Further research is warranted to optimize mutant viral vectors for clinical applications.